Educating patients about this relationship helps them understand the impact of food on insulin requirements and blood glucose control
OSA is highly prevalent both in the United States and globally, affecting more than 18 million Americans, and approximately 1 billion people worldwide [3, 4]
The most common side effects are gastrointestinal, including nausea, vomiting, diarrhoea, and abdominal discomfort, which may be more pronounced in post-bariatric patients
Accuracy and Acceptability of Wrist-Wearable Activity-Tracking Devices: Systematic Review of the Literature
Zepbound cravings control is a significant benefit reported by patients
In clinical trials, people using GLP-1 drugs lost an average of about 10 pounds more than people using a placebo